X0306 4 2013-08-27 0 0001368993 WaferGen Bio-systems, Inc. WGBS 0001474528 Coradini Robert C/O WAFERGEN BIO-SYSTEMS, INC. 7400 PASEO PADRE PARKWAY FREMONT CA 94555 1 0 0 0 Common Stock 2013-08-27 4 A 0 70218 A 73382 D Common Stock 2013-08-27 4 A 0 62500 A 135882 D Series A-1 Convertible Preferred Stock 2013-08-27 4 D 0 24038.46 D Common Stock 2419 0 D Common Stock Warrant (right to buy) 61.62 2013-08-27 4 D 0 4625 D Common Stock 4625 0 D Convertible Promissory Note due 11/27/2014 56.65 2013-08-27 4 D 0 139811 D Common Stock 2468 0 D Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 19386 A 2013-08-27 2018-08-27 Common Stock 19386 19386 D Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 31250 A 2013-08-27 2018-08-27 Common Stock 31250 31250 D The securities were convertible into common stock at any time following their issuance on May 27, 2011, on a 9.939-for-1 basis, and had no expiration date. The reporting person disposed of 24,038.46 shares of Series A-1 convertible preferred stock, 4,625 common stock warrants and a convertible promissory note with a principal amount of $139,811, including accrued interest, in exchange for 70,218 shares of common stock and 19,386 common stock warrants in an issuer exchange transaction. The securities were convertible into common stock at any time following their issuance on May 27, 2011, until their expiry five years thereafter. The principal amount of the security includes interest earned from their issuance on May 27, 2011, up until August 27, 2013, and was convertible into Series A-2 convertible preferred stock, in whole or in part, at any time following their issuance, from time to time, with no expiration date. Each share of Series A-2 convertible preferred stock was convertible into common stock at any time on a 9.939-for-1 basis, with no expiration date. The reported securities are included within 2.5 Units acquired by the reporting person from the issuer in a private placement for $50,000 per Unit. Each Unit consists of twenty five thousand (25,000) shares of common stock and twelve thousand five hundred (12,500) warrants to purchase one share of common stock. On August 27, 2013, the common stock of WaferGen Bio-systems, Inc. was subject to a 1-for-99.39 reverse split. All dispositions, acquisitions and conversion ratios are recorded on a post-split basis. /s/ Robert Coradini 2013-08-29